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Prosthetic valveAbstract Objectives: To describe the incidence, clinical characteristics, microbiological proﬁle and
in-hospital outcome of infective endocarditis (IE) in our center.
Methods: A prospective study that was conducted on 50 consecutive patients admitted to our car-
diology department diagnosed as Duke deﬁnite IE. The study was conducted for a period of one
year and started on the 1st of September 2009 till the end of August 2010. All patients were sub-
jected to detailed history taking, clinical examination, blood culture and echocardiography.
Results: The study was carried out on 29 males (58%) and 21 females (42%) with a mean age of 33
years. The mean duration of delay from onset of symptoms till diagnosis was 54 days. Native valve
endocarditis was found in 34 patients (68%). Blood cultures were positive in 27 patients (54%).
Staphylococci were the prevalent microorganisms (52%). In-hospital events included: heart
failure in 29 patients (58%), systemic embolization in 13 patients (26%), para-valvular abscess in
8 patients (16%), septic pulmonary emboli in 7 patients (14%), dehiscence of prosthetic valves in
5 patients (10%) and renal failure in 2 patients (4%). Surgical intervention was indicated in 41
patients (82%). Only 16 patients (39%) had early surgical intervention. In-hospital mortality was
22%. However, the mortality rate improved in the patients who had undergone early surgical inter-
vention (18.75% versus 32%).
Conclusions: Infective endocarditis remains a major health problem. It carries high in-hospital
events with a high mortality rate. Delayed diagnosis of the disease and culture negative IE are com-
mon. Staphylococci are the prevalent microorganisms. Early surgical intervention improves sur-
vival.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Infective endocarditis (IE) is a non-contagious infection of the
lining of the heart chambers and heart valves, caused by bac-
teria, fungi, or other infectious agents.1 IE is a peculiar disease
for at least three reasons. First, neither the incidence nor the
mortality of the disease has decreased in the past 30 years.2
308 M. Sadaka et al.Secondly, IE presents in a variety of different forms. For this
reason, IE requires a collaborative approach, involving pri-
mary care physicians, cardiologists, surgeons, microbiologists,
infectious disease specialists, and frequently others, including
neurologists, neurosurgeons, radiologists, and pathologists.3
Thirdly, guidelines are often based on expert opinion.4 The
incidence of IE ranges from one country to another within
3–10 episodes/100,000 persons per year.5 A recent systematic
review of 15 population-based investigations accounting for
2371 IE cases from seven developed countries (Denmark,
France, Italy, The Netherlands, Sweden, the UK, and the
USA) showed an increasing incidence of IE associated with a
prosthetic valve, an increase in cases with underlying mitral
valve prolapse, and a decrease in those with underlying rheu-
matic heart disease.6 The epidemiology, clinical and microbio-
logic spectra of IE is signiﬁcantly different in the developing
countries compared to the western world. These differences
can be attributable to multiple factors present in poorer coun-
tries including: signiﬁcantly higher incidences of rheumatic
heart disease and uncorrected congenital heart disease, exces-
sive and improper use of antibiotics, late clinical presentation,
and worse outcomes.7 In addition, developing countries may
have a higher incidence of culture negative endocarditis than
in the western world, largely secondary to prior doctor-pre-
scribed or self administered antibiotic use. Life-threatening
complications from IE are still common despite echocardio-
graphic diagnosis and the use of effective antibiotics.7
Several exciting developments offer the prospect of im-
proved prevention and treatment of IE. Vaccines targeted at
speciﬁc bacterial adhesions may inhibit valve colonization,
and newer antibacterial agents with novel effects may attenu-
ate the invasive properties of virulent organisms such as Staph
aureus.8 Finally, modiﬁed biomaterials in development may re-
duce the risk of IE in patients with artiﬁcial heart valves or
other intra-cardiac prosthetic material. At the end, despite
these advances, the diagnosis and management of IE remain
a considerable challenge across the range of medical
disciplines.
The main aims of our study are to prospectively describe
the incidence, clinical characteristics, microbiological proﬁle
and in-hospital outcome of infective endocarditis in our center.
2. Methods
This is a prospective study that was conducted on 50 patients
admitted to our cardiology department diagnosed as Duke
deﬁnite infective endocarditis.9 The study was conducted for
a period of one year and started on the 1st of September
2009 till end the of August 2010. Exclusion criteria included:
patients who proved to have any source of infection other than
IE and those with clinical suspicion of IE who could not be
categorized as deﬁnite IE according to the guidelines on the
prevention, diagnosis and treatment of Infective Endocarditis
of the European society of Cardiology (ESC).9
Structured data collection sheet was used to record the
data, it included: I- Questionnaire on: demographic data, clin-
ical presentation at admission, duration of symptoms, prior
use of antibiotics, diagnosis delay and in-hospital course and
outcome. II- Clinical features:9 new cardiac murmurs or man-
ifestation of heart failure, peripheral signs of IE (e.g. Osler’s
nodes, Janeway lesions, and splinter hemorrhages.), clubbingof the nails, splenomegaly, and complications related to sys-
temic embolization: (e.g. neurological manifestation, pulmon-
ary embolization, and peripheral ischemia). III- Laboratory
data: complete blood picture, renal functions, liver transami-
nases, ESR, CRP and Blood cultures: Ten ml of blood was col-
lected for blood culture under strict aseptic technique, to be
added directly to a Signal blood culture bottle (Oxoid) (a sys-
tem that employs a single bottle capable of supporting the
growth of both aerobic and anaerobic bacteria). Three sets
were obtained with a time interval of at least one hour in-be-
tween and within a maximum of 48 h. All bottles were incu-
bated for a total period of 21 days. Positive blood cultures
were subjected to: Gram and Ziehl–Neelsen stained smears.
Subcultures were made onto blood agar, (Columbia agar base
supplemented with 5% deﬁbrinated blood, Oxoid), Chocolate
agar and MacConkey’s agar. The plates were incubated for
24 h in a 5% enriched CO2 at 37 C both aerobically and aner-
obically. Subcultures were also made on Sabouraud dextrose
agar slopes (Oxoid) incubated at 30 C for at least 2 weeks
(for possible fungal etiology). Bacterial identiﬁcation was per-
formed according to standard microbiological procedures
(Gram stained ﬁlms, catalase and coagulase tests, growth on
bile esculin medium, sensitivity to bacitracin and optochin, su-
gar fermentation, pattern of growth on triple sugar iron, test-
ing for oxidase, urease, citrate and indole, amino acid
decarboxylation and motility). Routine antibiotic sensitivity
testing was done by the disk diffusion method (Oxoid) accord-
ing to guidelines of the Clinical Laboratory Standards Institute
(CLSI). IV- Radiological examination: chest X-ray was done
for all patients in this study. Other imaging modalities were
done when indicated in some cases: CT of brain or MRI if pre-
sented with neurological symptoms, CT of chest if pulmonary
septic emboli were suspect, U/S abdomen or even CT of abdo-
men was done whenever abdominal organ embolization is sus-
pected and Duplex ultrasound was performed in the case of
suspected ischemic extremities due to embolization. V-Echo-
cardiographic examination: transthoracic echocardiography
(TTE) examinations were performed on all patients using the
Envisor-CHD, Philips echocardiography machine. Trans-
esophageal echocardiography (TEE) was performed in 27 pa-
tients using Omiplane-III probe. Images were recorded in
digital loop display format. Both studies focused on: (Calcula-
tion of the left ventricular ejection fraction (EF), site, size,
number and mobility of the vegetations, the presence of valvu-
lar damage and/or regurgitation, intra-cardiac abscesses, pros-
thetic valve dehiscence, para-valvular leakage and intra-
cardiac ﬁstula).
2.1. Statistical analyses
After data entry into a specially designed sheet using Microsoft
Excel, a printout of the data was thoroughly revised. Then the
ﬁle was transferred into Statistical Package for Social Science
(SPSS, Chicago, IL, USA) version 17 formats. Normality test
was performed and as most of the variables resulted in insignif-
icant Kolmogorov–Smirnov which indicates that the variables
were considered to be -normally distributed and were dealt
with using parametric statistics. Scale variables were compared
using independent Student’s t test, while categorical data were
compared using the Chi square test. Repeated measures were
compared using the paired t test. Sensitivity analysis was
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0.05 level of signiﬁcance (alpha error) and beta error was set
to be 20%.
3. Results
3.1. Demographic data
Fifty consecutive patients were included in this prospective
study. All patients were diagnosed to suffer from deﬁnite infec-
tive endocarditis based on the modiﬁed Duke criteria.1 Two of
our patients gave history of prior IE one year before their re-
cent admission. The ﬁrst one had a recurrence on top of an in-
tra-cardiac device and the second one on top of an aortic
prosthesis. There were 29 males (58%) and 21 females (42%)
while the age of studied patients ranged between 16 and
78 years with a mean age of 33.42 ± 11.37 years.
3.2. Diagnosis delay
The mean time from symptom onset to diagnosis was relatively
long. The diagnosis delay ranged between 4 days and
210.0 days with a mean of 54.62 ± 49.75. Diagnosis delay less
than 30 days was encountered in 32% of the studied patients
while, 42% had diagnosis delay that ranged between 30 and
60 days ,14% had diagnosis delay that ranged between 61
and 90 days and 12% were diagnosed after 90 days from the
onset of illness. The distribution of the studied cases according
to the duration of diagnosis delay is shown in ﬁg. 1.
3.3. Referral Sites of the patients
The patients were referred to our department from multiple
different referral sites; 17 patients (34%) from internists, 13 pa-
tients (26%) presented in the emergency department with
unsettled diagnosis, 8 patients (16%) were referred from cardi-
ologist outpatient clinics, while 5 IE cases (10%) were referred
from private hospitals and 4 patients (8%) from public hospi-
tals and three patients (6%) from the internal medicine depart-
ment in our university hospital.
3.4. Clinical characteristics
Based upon the modiﬁed Duke’s criteria,1 27 patients (54%)
had two major criteria and 23 patients (46%) had 1 major
+3 minor criteria. All our patients (100%) had fever with
the temperature ranging between 38 and 40 C followed by
dyspnea grade (III–IV) in 29 patients (58%). NeurologicalFigure 1 The percentage of patients according to the duration of
diagnosis delay in days.deﬁcits were reported in 7 patients (14%), hemiparesis oc-
curred in 5 of them; one case had TIA (transit ischemic attack),
and the last case suffered from low back pain complicated by
paraplegia; Magnetic resonant imaging of that patient revealed
a vertebral septic lesion. During the initial physical examina-
tion, cardiac murmurs were heard in 40 patients (80%).
3.5. Extra-cardiac manifestations
Beside the embolic neurological complications previously men-
tioned, splenomegaly was found in 9 patients (18%), 4 of them
(8%) had splenic infarction. Pulmonary embolization was
diagnosed in 7 patients (14%); 6 of them had right sided IE
secondary to intravenous drug abusers (IVDA). Peripheral
arterial embolisation was found in 2 patients (4%). Two pa-
tients (4%) had renal impairment necessitating dialysis Fig. 2.
3.6. Presumed source of infection
The majority of cases; 27 patients (54%) were admitted with-
out deﬁnite presumed source. IE secondary to intravenous
drug abuse (IVDA) was detected in 13 patients (26%). The his-
tory of preceding dental interventions was recorded in only 4
patients (8%). History of gastrointestinal (GIT) or Genitouri-
nary (GU) procedures before IE was mentioned in 3 patients
(6%). Cardiac catheter-related bacteremia was seen in 2 pa-
tients (4%) and one case (2%) had a history of prior surgery
(appendicectomy) Fig. 3.
3.7. Preexisting cardiac disease
Twenty-eight patients (56%) had preexisting cardiac disease,
while 22 patients (44%) did not show a preexisting cardiac le-
sion. Thirteen out of the 22 patients were IVDAs while the
remaining nine patients showed structurally normal hearts.
The natures of the preexisting cardiac diseases among our
studied patients were demonstrated in Table 1.
3.8. Type s of IE according to the localization of infection and
the presence or absence of intra-cardiac materials
The left side of the heart alone was involved in 30 patients
(60%); 18 patients (36%) had the disease on the left sided0
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Figure 2 Showing the distribution of the cases according to the
clinical presentation.
Figure. 3 Percentage of presumed sources of infection in the
studied cases.
Table 1 Distribution of the patients according to preexisting
cardiac disease.
Preexisting cardiac diseases No. %
Previous valve surgery 11 22
Early prosthetic valve IE 4 8.0
Late prosthetic valve IE 7 14
RHD 8 16
Congenital heart disease 4 8.0
CTGA 1 2.0
VSD 1 2.0
Subaortic membrane 1 2.0
Bicuspid aortic valve 1 2.0
Intra cardiac devices 3 6.0
MVP with MR 1 2.0
HOCM 1 2.0
RHD: rheumatic heart disease CTGA: corrected transposition of
great arteries. VSD: ventricular septal defect HOCM: hypertrophic
obstructive cardiomyopathy. MVP: mitral valve prolapsed MR:
mitral valve regurgitation.
Table 2 Distribution of cases according to the localization of
infection.
Side No. %
Left sided IE 30 60.0
Native 19 38.0
Prosthesis 11 22.0
Right sided IE 16 32.0
Left and right sided IE 3 6.0
Intra-cardiac device Related 3 6.0
Extra-cardiac device Related 1 2.0
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sided prosthesis and one patient (2%) with hypertrophic
obstructive cardiomyopathy (HOCM) showed the vegetation
on the interventricular septum. The mitral valve was affected
in 14 patients (28%), 7 on native mitral valves and an equal
number on top of mitral valve prosthesis. The aortic valve
was involved in 10 cases (20%), 8 on native aortic valves
and 2 on aortic valve prosthesis. Both mitral and aortic valves
were affected in 5 patients (10%); combined native mitral and
aortic valves infections were encountered in 3 patients while
the other 2 patients had a double prosthesis IE.
The right side of the heart alone was involved in 16 patients
(32%). The tricuspid valve alone was affected in 11 patients
(22%) of right sided IE while the pulmonary valve was affected
in one IVDA case (2.0%). One case (2%) had IE on the right
side of VSD (outlet type) (2.0%). Intra-cardiac devices IE were
diagnosed in the remaining 3 patients (6.0%).
Combined right and left sided (IE) was diagnosed in 3 pa-
tients (6%). Extra cardiac IE was diagnosed on top of the
conduit graft from pulmonary trunk to the right ventricle in
a case with transposition of the great arteries (TGA) (2 %.).
Surgical procedure was done 6 years before IE had occurred.The distribution of the studied patients according to the local-
ization of infection is summarized in Table 2.
3.9. Blood cultures
A single positive blood culture was discarded for establishing
the diagnosis of IE for the possibility of potential contami-
nants. According to the yield of the blood cultures, our results
were divided into two groups: negative blood culture in 23 pa-
tients (46%) and positive blood culture in 27 patients (54%).
3.10. Negative Blood cultures
Culture-negative endocarditis (CNE) was deﬁned as endocar-
ditis with failure to identify the organism following inoculation
of at least three independent blood samples in a standard
blood culture system with negative cultures after at least seven
days of incubation and subculturing. Blood cultures were neg-
ative in 23 patients (46%). Seventeen patients (73.9%) out of
the 23 CNE gave history of the prior use of antibiotics ,while
5 patients (21.7%) with negative blood cultures did not receive
antibiotics. In one patient (4.3 %) the issue of prior use of anti-
biotics was not certain.
3.11. Positive blood cultures
Blood cultures were positive in 27 patients (54%). Gram-posi-
tive bacteria were the prevailing organisms representing
81.48% of positive blood cultures (22 isolates). Staphylococci
were isolated in 14 patients (51.8%) followed by streptococci
in 8 patients (29.6%). Gram –negative bacilli were isolated in
only 4 patients (14.8%). These included 2 Pseudomonas, 1
Klebsiella and 1 E-coli isolates. Candida spp. was isolated in
only one case. Table 3.
3.12. Echocardiography examination
Transthoracic echocardiography (TTE) was performed in all
our cases. Vegetations were detected by TTE in 40 patients
(80%). Left ventricular ejection fraction (EF) ranged from
40.0 to 85.0% with a mean of 61.68 ± 9.05%. Transesopha-
geal echocardiography (TEE) was indicated in 27 patients;
13 patients with native valve endocarditis, all patients with
prosthetic valve endocarditis (n= 11) and 3 cases with IE
complicating pacemaker devices. Vegetations were presented
in 41patients (82%) of all cases both by TTE & TEE. Intra-
cardiac abscesses were detected in 9 patients (18%); six of them
were aortic root abscesses, two were mitral annular abscess
and one inside the right ventricle in relation to an infected pace
Table 3 Microbiology proﬁle in the culture positive group.
Identiﬁed microorganism No.=27 54% of total cases of IE
Staphylococci 14 51.8
Coagulase negative 7
Coagulase positive
methicillin sensitive
4
Coagulase positive
methicillin resistant (MRSA)
3
Streptococci 8 29.6
Alpha-hemolytic streptococci 4
Non hemolytic streptococci 4
Gram negative bacilli: 4 14.8
Fungi: Candida 1 3.7
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was encountered in two patients. The all echocardiographic
data are summarized in Table 4.
Fig. 4 demonstrated different varieties of echocardio-
graphic ﬁnding in a sample of studied cases.
3.13. Other Radiological examinations
Ultra sound abdomen: revealed splenic infarction in four pa-
tients. CT brain: revealed embolic brain infarctions in seven
patients. Two more patients suffered from subarachnoid hem-
orrhage. MRI showed an extra dural ring –enhancing lesion
(abscess) measuring about 1 cm indenting the left antro-lateral
aspect of the thecal sac and compromising the related nerve
roots at the level of LV2–3 and LV4 in one case.
3.14. Major complications and in-hospital mortality
Advanced heart failure, NYHA functional class III-IV: Heart
failure represented the most frequent complication among
our studied patients. Heart failure occurred in 29 patients
(58%). The leading cause of heart failure was valvularTable 4 The results of the echocardiographic ﬁndings among
the studied patients.
1-Site of involvement No. Percentage
Mitral valve 14 28.0
Aortic valve 10 20.0
Tricuspid valve 11 22.0
Mitral and aortic valves 5 10.0
Aortic and tricuspid 2 4.0
Mitral and tricuspid 1 2.0
Pulmonary valve 1 2.0
Non-valve structures: 6
Pacemaker 3
HOCM(IVS) 1
VSD(outlet) 1
CTGA 1
2-Nature of the valve
Native 33 66.0
Prosthesis 11 22.0
3-Identiﬁed lesions
Vegetations 41 82.0
Abscess 9 12.0insufﬁciency. Left sided heart failure secondary to native val-
vular regurgitation was encountered in 14 patients. Seven pa-
tients had tricuspid valve regurgitation and right sided heart
failure. Three patients had combined left and right sided valves
regurgitation and presented with biventricular failure. Five pa-
tients had left sided prosthetic valves dehiscence and peri-val-
vular regurgitation. Systemic and pulmonary Embolization:
Systemic embolization occurred in 13 IE patients (26%). No
hemorrhagic strokes occurred in 6 patients. Four patients suf-
fered from splenic infarction and 2 patients had peripheral
arterial embolization. One patient presented with septic em-
bolic focus in the vertebrae. Pulmonary emboli were diagnosed
in 7 patients (14%) with right sided IE secondary to IVDAs.
The risk of embolism was related to the size and mobility of
the vegetations. This relation is shown in.Table 5 Peri-annular
complications: extension of the infection and intra-cardiac ab-
scesses were detected by TEE in 9 patients. Prosthetic valves’
dehiscence was detected in 5 patients. Renal failure requiring
dialysis: two patients suffered from acute renal failure that
necessitated dialysis, their serum creatinin was 2.3 and
2.9 mg/dl. One of those patients died during his hospital stay.
Intracranial hemorrhage: Two patients died from intracranial
hemorrhage. Septic shock: Two patients developed fulminant
sepsis and they were mechanically ventilated and died from
septic shock.
3.15. In-hospital mortality
Eleven patients (22%) died during their hospital stay. The
leading causes of death were: three patients died postopera-
tively, two from heart failure, two from intracranial hemor-
rhage, two from septic shock, one from renal failure and
another one from non-hemorrhagic stroke. Eight (72.7%) of
the dead patients had positive blood cultures. The isolated
organisms were staphylococci (4 cases), gram-negative bacilli
(2 cases), with fungal infection in one and streptococci in an-
other one. Diagnosis delay ranged between 4 days and
210 days with a mean of 54.62 ± 49.75. This delay had a direct
impact on the mortality. Delayed diagnosis was associated
with increased mortality rate as seen in Table 6.
3.16. Surgical treatment
For all patients, management including indication for surgery
was based upon the latest ESC guidelines for the management
of infective endocarditis13. Nine patients (18%) were assigned
for medical treatment and they responded favorably. Surgery
was indicated in 41 patients (82%). However, it was performed
in only 16 patients (32%). The other twenty-ﬁve patients did
not receive surgical management (50%). The mortality rate
was high in the later group compared to those who underwent
surgical intervention (32% versus 18.75%). Most patients had
more than one indication for surgery. Congestive heart failure
and large vegetations were the main indications for surgical
intervention. The indications of surgical treatment and mortal-
ity according to surgery status are summarized in Table 7.
3.17. Study results concerning the mode of acquisition
Community acquired infection occurred in 32 patients (64%),
followed IVDAs in 13 patients (26%) , then health care
associated IE in 5 patients (10%) following balloon mitral
A B
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Figure. 4 Echocardiographic diagnosis of various types of infective endocardities. (A) large vegetations on the mitral valve, (B)
transoesophageal long axis view showing mitral annular abscess complicating prosthetic mitral valve endocardities, (C) aortic valve
vegetations with aortic root abscess, (D) vegetations on the right side of outlet ventricular septal defect as seen in parastenal short axis
view.
Table 5 The distribution of the embolic events regarding the
size of vegetations.
Size of vegetations No of embolic events (%)
P15 mm 10(20)
>10 and 615 mm 5(10)
610 mm 4(8)
No vegetations (abscess) 1(2)
312 M. Sadaka et al.valvuloplasty, cardiac catheterization and neglected central
catheters (10%).
3.18. Microbiological proﬁle based on the mode of acquisition
Community acquired IE (32 patients): blood cultures were posi-
tive in 17 patients (53.1%). Staphylococci were isolated in 9Table 6 The relation between in-hospital mortality and
Duration in days No. of patients No
<30 16 2
30–60 21 6
61–90 7 2
>90 6 1
MCp: p value for Monte Carlo test,*percentage was calculapatients (52.9% of the identiﬁed organisms in this subgroup),
followed by streptococci identiﬁed in 7 patients (41.2%) and
gram negative bacilli were isolated in one patient (5.8%). Fun-
gi were not isolated in this subgroup.
Intravenous drugs abuse IE (13 patients): blood cultures
were positive in ﬁve cases (38.5%). Staphylococci were isolated
in 2 patients (40% of the identiﬁed organisms in this sub-
group). Gram-negative bacilli were isolated in another 2 pa-
tients (40%). Candia was isolated in one patient (20%).
Health care associated IE (5 patients): blood cultures were
positive in all the ﬁve cases (100%). Staphylococci were iso-
lated in three patients (60% of the identiﬁed organisms in this
subgroup). Streptococci were isolated in one patient (20%).
Gram-negative bacilli were isolated in another patient (20%).diagnosis delay.
. of death *Mortality rate MCp
12.5 0.722
28.57%
28.57%
16.66%
ted from the diagnosed patients in each duration.
Table 7 Distribution of the studied cases according to the
indications of surgery.
Indication of surgery No. %
Heart failure 29 58.0
Large size of vegetation P15 mm 20 40.0
Embolic event* 13 26.0
Peri-annular complications
Abscess 8 16.0
Dehiscence 5 10.0
Uncontrolled infection 4 8.0
Pacemaker related abscess 1 2.0
Recurrent IE 2 4.0
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IE and its predisposing risk factors have changed over time
with the emergence of IVDA; intravascular prostheses, noso-
comial exposure, hemodialysis, and age-related valvular sclero-
sis which are more prevalent than rheumatic heart disease,
especially in the developed countries.2 Our study was carried
on all cases of IE admitted to the cardiology department of
the Alexandria main university hospital during a one year per-
iod. We did not exclude any cases diagnosed as Duke-deﬁnite
IE and the total number of cases during this year was 50
patients.
4.1. Demographic data
The present study showed a higher incidence of IE in males
(58%) than in females (42%) with a ratio of 1.4:1. this is com-
parable to what was reported by Beynon RP et al.10 in which
he stated that the male: female ratio is 2:1. Tariq M. et al.11
also found that the male: female ratio was 1.8:1.
The mean age in our study was 33.42 ± 11.37 years as sim-
ilar to what was found in most studies in developing countries.
Ullah et al.12 found that most of the patients belong to the
younger age group, with almost 90% falling below 40 years.
Majority of the researchers from developing countries report
a similar age group affected, including Rehman S et al.13 and
Tariq M et al.11 Also, Koegelenberg et al.14 found that patients
with deﬁnite endocarditis had a mean age of (37.7 years) and in
Kaser-Elini study by Al-Mogheer et al.15 the mean age was
(32 ± 13 years). In developed countries Hill et al.16 mentioned
that more than one-half of all IE cases in the United States and
Europe occur in patients over the age of 60 years, and the med-
ian age of patients has increased steadily during the past
40 years. This trend is probably due to two factors: the decline
in the incidence and importance of rheumatic heart disease as a
risk factor for IE and the increasing proportion of elderly sub-
jects in the general population who are more likely both to de-
velop degenerative valve disease and to require valve
replacement, which is associated with an increased risk of IE.
While Wilson LE et al.17 said that IE is now more-often ob-
served in new at-risk groups in industrialized countries, includ-
ing IVDA (mean age 30–40 years) and adults, including elderly
individuals (>65 years) with valve prostheses or chronic
healthcare-associated conditions. (This means that patients
with chronic health conditions are associated with frequent
hospitalization and intravenous drug therapy e.g. chronic renal
failure, long term insertion of central lines, cancer patients on
regular chemotherapy cycles).4.2. Diagnosis delay
Diagnosis delay in the present study ranged from 4 to 210 days
with the mean of 54.62 days while the median was 40 days; in
Kaser Elini the mean was 65 ± 96 days 15 near to our diagnosis
delay. Van Le et-al.18 in the study of serious complications after
IE found that the range to diagnosis was 0–103 days, this also
reported by Hasbun et al.19 The median diagnostic delay for
IE in our study was 40 days while Hill et al showed the median
time between the onset of symptoms and the diagnosis of IE was
8 days.16 The prolonged time of diagnosis delay may be due to;
decreased awareness of the treating physicians and general prac-
titioners of the disease and the importance of early diagnosis,
symptomatic treatment of fever without searching for underly-
ing etiologies and the empirical use of self prescriptions of anti-
biotics by Egyptian patients and even pharmacists as well.
4.3. Presumed source of infection
The majority of cases in the present study; 54% were admitted
without deﬁnite presumed source of infection, on the other
hand no deﬁnite source of bacteremia was identiﬁed in
71.8% of IE patients studied by Adrian C et al.20 Followed
by IVDA; 26% of our studied patients, while Frontera JA
et-al.21 reported that the incidence of IE among IVDAs is be-
lieved to be 100–1000 times. In our study dental procedure was
recorded in 8% of patients similar to what was reported in the
2007 American Heart Association (AHA) guidelines, in a ser-
ies of 17 IE cases 8% that had dental interventions within
3 months before IE diagnosis.22 Also 8% of IE patients in
the present study had previous procedures (6%), genitourinary
procedures and 2% anorectal procedures, this is near to the
incidence which was reported in the same AHA guidelines,
as in a series of 20 cases (9%) that had invasive anorectal
and genitourinary procedures. In the current study, catheter
induced IE was reported in 2 patients (4%) of IE cases; one
case after percutaneous mitral balloon valvotomy (2%) and
the other cases (2%) had coronary angiography in rheumatic
heart disease (RHD) before valve replacement surgery. AL-
Aghbari et al.23 reported one case with IE post percutaneous
mitral balloon valvotomy.
4.4. Pre-existing cardiac disease
In the current study 18% had no underlying cardiac disorder
or were from IVDAs group. In a French study 47% of patients
with IE presented without previous history of any underlying
cardiac disorder.24 In our study, the incidence of RHD within
IE cases was 16% nearly similar to studies from Hong Kong
and Thailand that found RHD in 18% and 12% of cases,
respectively.25 While a study from Singapore,26 mentioned
RHD in only 4% of IE cases also Marijon et al.27 found that
the prevalence of IE in RHD was 2.2 per 1000. This difference
between those studies may be due to increase in the prevalence
of RHD in developing countries.
During the last 20 years, only 33 cases of IE complicated
hypertrophic cardiomyopathy (HCM) were published.28 IE
complicating HCM is not commonly reported but occurs al-
most universally in patients showing evidence of outﬂow tract
obstruction. In our study, only one patient (2%) had IE on top
of HCM with outﬂow obstructive to be concordant to many
studies. The estimated cumulative 10-year probability of
314 M. Sadaka et al.developing IE in obstructive HCM is <5%. In the most com-
prehensive study of prevalence and incidence, Spirito et al.28
identiﬁed 10 patients with HCM and endocarditis, outﬂow
tract obstruction and atrial dilatation present in all cases.
In our present study, PVE was reported in 22% of all cases
of IE, similar to Rivas P et al.29 who reported that the IE
developing on prosthetic valves accounts for 15–32% of all
cases of IE, and in Kaser-Elini study prosthetic valves account
for 20.6% of all cases.15
As regards intra cardiac devices, in our study 6% of all IE
cases is in agreement with the reported rate of infection rang-
ing from 0.13% to 19.9% for permanent pacemakers (PPMs)
and from 0.7% to 1.2% for intra-cardiac deﬁbrillators
(ICDs).30
The relative incidence of IE in congenital heart disease
(CHD) had increased because of improved survival with
CHD.31 CHD with IE was reported in 8% of the studied cases,
on the other hand Rathor et al.32 in the retrospective study of
IE, reported that the incidence of IE in CHD was 2.2%. While
Tariq M et al.7 found that 31% of IE patients had underlying
CHD. The differences between studies may be related to the
variation in the use of antimicrobial prophylaxis before differ-
ent procedures and the proper early identiﬁcation of the CHD
cases.
The current study showed that only 2% had MVP with mi-
tral regurgitation, near to the incidence recorded by Al -Agh-
bari et al.23 in Yemen as the MVP in their studied cases was
recorded in 2.8% only. Steckelberg JM et al.33 reported that
the risk of IE per 100,000 patient-years was 4.6 in patients with
MVP without an audible cardiac murmur and 52 in patients
with MVP with an audible murmur of mitral regurgitation.
4.5. Blood cultures
In the current study, 46% of patients were found to have neg-
ative blood culture. This ﬁnding is consistent with other studies
from developing countries.11,13 However, Krcmary et al.34 and
Omezzine-Letaief35 from developed countries have also re-
ported similar percentages of culture negative cases. While
comparing with other studies, Chen CH et al.36 reports
5.2%, Zamorano J et al.37 8.7% and in the USA, ‘culture neg-
ative’ endocarditis constitutes only 2.5–30% of all IE diag-
nosed cases.38 This low culture positivity/high culture
negativity is understandable as most patients in our country
like other underdeveloped countries receive unjustiﬁed antibi-
otics prior to admission in hospital, while consulting area doc-
tors or even pharmacists. Similarly, in this study, a signiﬁcant
association is seen between previous intake of antibiotics and
culture negative endocarditis.
Positive blood culture is a major diagnostic criterion for IE.
Blood cultures were positive in our study in 54% while ESC
reported that the positive blood culture is the most important
category, representing 85% of all IE. Failure to culture the
organism in IE may result from inadequate anti microbial
technique, infection with highly fastidious bacteria or non bac-
terial organism or most importantly, from the administration
of antimicrobial agents before blood cultures are obtained.12
The organisms found in the present study are as follows:
Staphylococcus group was found in 14 patients (51.85%),
streptococcus group in 8 patients (29.63%), Gram-negative ba-
cilli 4 cases (14.82%) and fungi in 3.7%. Koegelenberg et al.14
reported the positive blood cultures in21 patients yielded thefollowing organisms: viridans streptococci in 6 patients
(28.6%), pneumococci in 2 patients (9.5%), group D strepto-
coccus in 1 patient (4.8%), other streptococci in 2 patients
(9.5%), staphylococci in 3 patients (14.3%), and 18.2% of
Gram-negative bacilli. In our result MRSA endocarditis oc-
curred in 6% of our patients in agreement of the study done
in Lebanon where MRSA endocarditis occurred in 7% of all
cases.39
4.6. TTE versus TEE ﬁndings
Over the last 20 years, the use of echocardiography has been
instrumental in conﬁrming the diagnosis of endocarditis. In
one study, reviewing 534 consecutive requests for TTE to ex-
clude IE, vegetations were found in only 4%.40 Thus, although
good quality TTE may exclude the diagnosis in patients at low
risk, a negative study does not exclude IE or its complications
if these are strongly suspected. In our results TTE was per-
formed in all cases of IE patients 50 (100%) and TEE in 27 pa-
tients (54%). TTE was positive in 40 subjects (80%) that were
in agreement with Nashmi A et al.41 who reported that TTE
showed vegetations in 37 patients (72.5%). In our study,
TEE were done in 27 patients, 10 cases (20%) with negative
TTE conﬁrmed to be positive by TEE and the other 17 cases
were positive by TTE and reconﬁrmed by TEE; thus the result
was positive in all cases subjected to TEE (100%) which was
similar to what was reported by Nashmi A et al.41 who men-
tioned that the TEE detected vegetation in 14 patients
(27.7%) in whom TTE was negative or questionable. On the
other hand, Evangelista A et al.42 reported that; for the detec-
tion of vegetations; TEE has a sensitivity of 90–100%, whereas
that of TTE ranges from 40% to 63%. They also reported that;
vegetation size also affects TTE sensitivity since only 25% of
vegetations <5 mm and 70% of those between 6 and 10 mm
were identiﬁed.5. IE reported complications
5.1. Heart failure
Heart failure (HF) is the most frequent complication of IE and
represents the most frequent indication for surgery in such
cases.43 Valve destruction causing acute regurgitation is the
most characteristic lesion leading to HF in native valve IE.9
In our study HF presented in 58% of the studied cases. Van
Le et al reported that HF was secondary to valvular insufﬁ-
ciency due to IE in 9% of the studied cases.445.2. Periannular complications
Extension of IE beyond the valve annulus is associated with in-
creased mortality, development of HF, and a higher likelihood
of surgery. In the current study; abscess was recorded in 18%
of the patients, and 44% of abscesses were detected by TEE.
These results were Similar to Anguera et al.45 who recorded
that Intra-cardiac abscesses occur in approximately 10% to
40% of cases of IE. In PVE the predominant complications
are peri-prosthetic leaks and dehiscence.46 In our study the
para-valvular leak was recorded in 50% of patients with
PVE (5 cases); on the other hand; David et al.47 found that
34.1% of patients with PVE had evidence of a prosthetic valve
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tation. The higher incidence of complications in our patients
with PVE could be related to the aggressiveness of infection,
delayed diagnosis and the early improper inefﬁcient antibiotic
prescriptions.
5.3. Embolic event
Dislodgements of part of vegetations of infected tissue or in-
tra-cardiac thrombi may cause embolic events, the most com-
mon complication during IE9,40 Embolic events are a frequent
and life-threatening complication of IE related to the migra-
tion of cardiac vegetations.9 In our research we found that
26% of IE cases presented with different sites due to systemic
embolization and this was comparable to Mocchegiani R et
al.49 who found that embolization occurs in 22–50% of cases
of IE. ESC also reported that embolic risk is very high in
IE, with embolic events occurring in 20–50% of patients,
12% of them to the spleen leading to splenic infarction associ-
ated with splenomegaly.9 While Anguera et al.45 considered it
as a rare complication that develops by bacteraemic seeding of
a mild infarction or due to the occlusion of splenic artery by
embolized vegetations, or it may follow an infected emboliza-
tion. Splenic infarction in our study presented in 4 cases (8%).
In our study of extremities distal embolization was recorded in
4% of the cases; 2% of them to the lower limb and 2% to the
upper limb. While Habib et al.9 found the incidence of extrem-
ities distal embolization was 13%. Those differences between
studies as regards distal embolization to the spleen or to the
extremities could be attributed to the difference in the duration
of studies and vegetation size. In our present study 14% had
pulmonary embolization and the highest incidence was with
IVDA as 71.5% of pulmonary embolization occurred with
IVDA. In agreement with Mathew et al.50 and Ruotsalainen
et al.51 who mentioned that right-sided IE frequently causes
pulmonary embolization that occurred in 40–75% of drug ad-
dicts who have tricuspid valve endocarditis.
5.4. Intracranial hemorrhage
The patients recorded as having intracranial hemorrhage in the
present study were only 2 (4%). Sonneville et al.52 reported
that the intracranial hemorrhage accounts for 12–30% of neu-
rologic complications of IE and even 29% of all neurologic
complications in critically ill patients with IE.
5.5. Renal failure
Decreased renal function at the time of hospitalization with IE
is an important prognostic indicator of a poor outcome.3 In
our study 2 patients (4%) were complicated by renal failure
in agreement with AL-Aghbari et-al.23 who documented renal
failure in 2 patients which represented 2.7% of his studied co-
hort. Miyake et al.53 also reported one case of renal failure that
developed as an initial manifestation of IE.
5.6. In-hospital mortality
In our result the in hospital mortality rate was 22% near the
retrospective cohort study in Turkey which was done by Erbay
et al.54 the in-hospital mortality rate was 27%. Also in Kaser-
Elini study by Al-Mogheer et al.15 the in-hospital mortalitywas 38.7% and the majority was due to CHF. On the other
hand in the studied conducted by Fedeli et al.55 the in-hospital
mortality was low, only 14%. The difference between our
study and the results of other studies may be attributed to a
small number of patients who underwent early surgical treat-
ment also those with delayed presentations with well estab-
lished complications. Recently a large multicenter study
showed that early surgery was associated with a decreased risk
of both in-hospital and late mortality.567. Treatment
Successful treatment of patients with IE relies on microbial
eradication by antimicrobial drugs and decreasing the risk of
systemic embolization by early surgical intervention for those
patients with large vegetations amenable for embolization.
7.1. Empirical Treatment
Treatment of IE should be started promptly after a minimum
of three sets of blood cultures.57 The choice of empirical ther-
apy based upon the guidelines; depends on many factors
including; whether the patient had received prior antibiotics,
on whether the infection was NVE or PVE, on whether PVE
infection is early (<12 months after surgery) or late
(>12 months after surgery), and on knowledge of the local
epidemiology, including antibiotic resistance and speciﬁc
blood-culture-negative pathogens.58 NVE and late PVE regi-
mens should account for the possibility of staphylococci, strep-
tococci, HACEK species and Bartonella species. Treatment
must be adjusted immediately after the diagnosis of the
pathogen.
7.2. Surgical treatment
Surgery is the treatment of choice in complicated PVE48. Ster-
ilization and ‘‘cure’’ by medical treatment alone are rarely pos-
sible in active NVE59. Surgery was indicated in 41 patients
(82%) in our study and was done in 39% and the most com-
mon indications for surgery were heart failure in 29 patients
(58%), large mobile vegetation in 20 cases (40%), and embolic
events in 13 patients (26%), not including pulmonary emboli.
Periannular complications in 10 patients (20%) while uncon-
trolled infection was seen in 4 cases (8%) and recurrence in 2
patients (4%). 37 cases had more than one indication for
surgery.
The most frequent indications recorded by Tornos et-al.43
were HF (60%), vegetation size (48%), refractory sepsis
(40%), and embolic complications (18%), with a combination
of these factors being present in many patients. Surgery was
performed in 21 patients (44.7%) in the study by Nashmi
et al.60 , they found that the most commonly encountered indi-
cations for surgery were large mobile vegetation in 7 (33.3%),
heart failure in 4 (19.0%) and severe valvular regurgitation 4
(19.0%); other indications included uncontrolled infection,
valvular ring abscess and systemic embolization.8. Conclusion
Based upon the results of our prospective study we concluded
that: the admission rate of IE in our department is not low, 50
316 M. Sadaka et al.cases were diagnosed over one year. The main varieties of IE
encountered in our study were: IE in IVDA (26%), PVE
(22%), IE without an identiﬁable structural heart disease
(18%) and IE on top of RHD (16%). Delayed diagnosis of
the disease is common among the studied patients. HF was
the most frequent and severe complication (58% of the pa-
tients). The 3 main complications of IE indicating early sur-
gery were heart failure, very large vegetations >15 mm and
embolic events. Staphylococci were the prevalent microorgan-
isms representing 51.8% of the total isolated microorganisms.
Culture negative endocarditis was common and it represented
46% of the studied cases. IE is associated with a high mortality
(22% in-hospital mortality).9. Study limitations
The main limitations to our study were; it was a single center
study, the short duration of the study (only one year), the rel-
atively small number of studied cases and the lack of long term
follow up of survived IE patients.
References
1. Millar BC, Moore JE. Emerging Issues in infective endocarditis.
Emerg Infect Dis 2004;10(6):1110–6.
2. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:
139–49.
3. Habib G. Management of infective endocarditis. Heart
2006;92:124–30.
4. Naber CK, Erbel R, Baddour LM, Horstkotte D. New guidelines
for infective endocarditis: a call for collaborative research. Int J
Antimicrob Agents 2007;29:615–6.
5. Hoen B, Alla F, Selton-Suty C, Beguinot I, et al. Changing proﬁle
of infective endocarditis: results of a 1-year survey in France.
JAMA 2002;288:75–81.
6. Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of
population-based studies of infective endocarditis. Chest 2007;132:
1025–35.
7. Tariq M, Karim B. Int J Collaborative Res Intern Med Public
Health 2009;1(3):84–99.
8. Prendergast BD. The changing face of infective endocarditis.
Heart 2006;92:879–85.
9. Habib G, Hoen B, Tornos P, Thuny F. Guidelines on the
prevention, diagnosis and treatment of infective enocarditis of
European Society of Cardiology (ESC). Eur Heart J 2009;
1–45.
10. Beynon RP, Bahl VK, Prendergast BD. Infective Endocarditis.
BMJ 2006;333:334–9.
11. Tariq M, Alam M, Munir G, et al. Infective endocarditis a ﬁve
year experience at a tertiary care hospital in Pakistan. Int J Infect
Dis 2004;8:163–70.
12. Khan NU, Farman MT, et al. Changing trends of infective
endocarditis. Natl Inst Cardiovasc Dis Karachi 2010;60(1).
13. Rehman S, Ghulam Shabbier, Shahid M. Clinical presenta-
tion of infective endocarditis. J Postgrad Med Inst 2002;16:
55–63.
14. Koegelenbergl CF, Doubell AF, et al. Infective endocarditis in the
Western Cape Province of South Africa: a three-year prospective
study. Q J Med 2003;96:217–25.
15. Al-Mogheer B, Ammar W, Bakoum S, et al. Predictors of in-
hospital mortality in patients with infective endocarditis. The
Egypt Heart J 2012. Article in press
16. Hill EE, Herijgers P, Claus P, et al. Infective endocarditis:
changing epidemiology and predictors of 6-month mortality: a
prospective cohort study. Eur Heart J 2007;28:196.17. Wilson LE, Thomas DL, Astemborski J, et al. Prospective study
of infective endocarditis among injection drug users. J Infect Dis
2002;185:1761–6.
18. Le V, Gill S. Serious complications after infective endocarditis.
Dan Med Bul 2010;57(10):A4192.
19. Hasbun R, Vikram HR, Barakat LA, et al. Complicated left-sided
native valve endocarditis in adults: risk classiﬁcation for mortality.
JAMA 2003;289:1933–40.
20. Pena AC, Tria R, et al. Infective endocarditis at the Philippine
heart center. Phil J Microbiol Infect Dis 1995;24(2):37–42.
21. Frontera JA, Gradon JD. Right-side endocarditis in injection drug
users: review of proposed mechanisms of pathogenesis. Clin Infect
Dis 2000;30:374–9.
22. Wilson W, Taubert KA, Gewitz M. Prevention of infective
endocarditis: guidelines from the American Heart Association: a
guideline from the American Heart Association Rheumatic Fever,
Endocarditis, and Kawasaki Disease Committee, Council on
Cardiovascular Disease in the Young, and the Council on Clinical
Cardiolog Y. Council on Cardiovascular Surgery and Anesthesia,
and the Quality of Care and Outcomes Research Interdisciplinary
Working Group. Circulation 2007;116(15):1736–54.
23. Khaled A, Yahya A, et al. Clinical features and outcome of
Infective endocarditis in Yamani patients treated with empirical
antibiotic therapy. Heart view 2010;11(1):2–9.
24. Hoen B, Alla F, Selton-Suty C, et al. Changing proﬁle of infective
endocarditis: results of a 1-year survey in France. JAMA
2002;288:75–81.
25. Yiu KH, Siu CW, Lee KL, Fong YT, et al. Emerging trends of
community acquired infective endocarditis. Int J Cardiol 2007;121:
119–22.
26. Liew WK, Tan TH, Wong KY. Infective endocarditis in
childhood: a seven-year experience. Singapore Med J 2004;45:
525–9.
27. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic
heart disease detected by echocardiographic screening. N Engl J
Med 2007;357:470–6.
28. Spirito P, Rapezzi C, Bellone P, et al. Infective endocarditis in
hypertrophic cardiomyopathy: prevalence, incidence, and indica-
tions for antibiotic prophylaxis. Circulation 1999;99:2132–7.
29. Rivas P, Alonso J, Moya J, et al. The impact of hospital-acquired
infections on the microbial etiology and prognosis of late-onset
prosthetic valve endocarditis. Chest 2005;128:764–71.
30. Klug D, Balde M, Pavin D, Hidden-Lucet F, et al. Risk factors
related to infections of implanted pacemakers and cardioverter-
deﬁbrillators: results of a large prospective study. Circulation 2007;
116:1349–55.
31. Li W, Somerville J. Infective endocarditis in the grown-up
congenital (GUCH) population. Eur Heart J 1998;19:166–73.
32. Yousuf RM, How SH, Fauzi ARM, et al. Infective endocarditis
in the east coast of peninsula Malaysia: a two year retrospective
survey from Kuantan. JK-Practitioner 2006;13(1):5–8.
33. Steckelberg JM, Wilson WR. Risk factors for infective endocar-
ditis. Infect Dis Clin North Am 1993;7:9–19.
34. Krcmery V, Gogova M, Ondrusova A, et al. Slovak endocarditis
study group etiology and risk factors of 339 cases of infective
endocarditis: report from a 10-year national prospective survey in
the Slovak Republic. J Chemother 2003;15:579–83.
35. Omezzine-Letaief A, Alaoui FZ, Bahri F, et al. Infectious
endocarditis with negative blood cultures. Arch Mal Coeur Vaiss
2004;97:120–4.
36. Chen CH, Lo MC, Hwang KL, et al. Infective endocarditis with
neurological complication: 10 year experience. J Mcrobiol Immu-
nol Infect 2001;34:119–24.
37. Zamorano J, Sanz J, Almeria C, et al. Difference between
endocarditis with true negative blood cultures and those with
previous antibiotic treatment. J Heart valve Dis 2003;12:256–60.
38. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N
Engl J Med 2001;345:1318–30.
Study of infective endocarditis in Alexandria main university hospitals 31739. Kanafani ZA, Mahfouz TH, et al. Infective endocarditis at a
tertiary care centre in Lebanon: predominance of streptococcal
infection. J Infect 2002;45(3):152–9.
40. Todd A, Leslie J, MacDougall M, et al. Clinical features remain
important for the diagnosis of infective endocarditis in the modern
era. Q J Med 2006;99:23–31.
41. Nashmi A, Memish ZA. Infective endocarditis at a tertiary care
centre in Saudi Arabia: review of 47 cases over 10 years. East
Mediterr Health J 2007;13:64–71.
42. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infec-
tive endocarditis. Heart 2004;90:614–7.
43. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endo-
carditis in Europe: lessons from the Euro heart survey. Heart
2005;91:571–5.
44. Van Le, Gill S. Serious complications after infective endocarditis.
Dan Med Bul 2010;57(10).
45. Anguera I, Del Rio A, Moreno A, et al. Complications of native
and prosthetic valve infective endocarditis: update in 2006. Curr
Infect Dis Rep 2006;8(4):280–8.
46. Jose´ MM, Ignasi A, Christopher CH, et al. The International
Collaboration on endocarditis merged database STUDY Group
Staphylococcus aureus native valve infective endocarditis: report of
566 episodes from the International Collaboration on endocarditis
merged database. Clin Infect Dis 2005;41(4):507–14.
47. Murdoch DR, Corey R. Clinical presentation, etiology, and
outcome of infective endocarditis in the 21st century The
International Collaboration on endocarditis–prospective cohort
Study. Arch Intern Med 2009;169(5):463–73.
48. Bannay A, Hoen B, Duval X, et al. For the AEPEI Study Group
The impact of valve surgery on short and long-term mortality in
left-sided infective endocarditis: do differencies in methodological
approaches explain previous conﬂicting results? Eur Heart J 2009.
49. Prendergast BD. Diagnostic criteria and problems in infective
endocarditis. Heart 2004;90:611–3.50. Mathew J, Addai T, et al. Clinical features, site of involvement,
bacteriologic ﬁndings, and outcome of infective endocarditis in
intravenous drug users. Arch Intern Med 1995;155(15):1641–8.
51. Ruotsalainen E, Sammalkorpi K, et al. Clinical manifestations
and outcome in Staphylococcus aureus endocarditis among
injection drug users and non addicts: a prospective study of 74
patients. BMC Infect Dis 2006;6:137.
52. Sonneville R, Mirabel M, Hage`ge D, et al. Neurologic complica-
tions and outcomes of infective endocarditis in critically-ill
patients: the ENDOREA prospective multicenter study. Crit Care
Med 2011.
53. Miyake M, Hatta K, Kameyama T, et al. Infective endocarditis
developing as uremia. Intem Med 2005;44:598–602.
54. Erbay AR, Erbay A, Canga A, et al. Risk factors for in-hospital
mortality in infective endocarditis: ﬁve years’ experience at a
tertiary care hospital in Turkey. J Heart Valve Dis 2010;19(2):216.
55. Fedeli U, Schievano E, Buonfrate D. Increasing incidence and
mortality of infective endocarditis: a population-based study
through a record-linkage system. BMC Infect Dis 2011;11:48.
56. Murdoch DR, Corey RG, Hoen B, et al. Clinical presentation,
etiology, and outcome of infective endocarditis in the 21st century:
the international collaboration on endocarditis-prospective cohort
study. Arch Intern Med 2009;169(5):463–73.
57. Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream
infections in adults: how many blood cultures are needed. J Clin
Microbiol 2007;45:3546–8.
58. Znazen A et al. High prevalence of Bartonella quintana endocar-
ditis in Sfax. Tunisia Am J Trop Med Hyg 2005;72:503–7.
59. Oakley CM, Hall RJC. Endocarditis: problems -patients being
treated for endocarditis and not doing well. Heart 2001;85(4):
470–4.
60. Cecchi E, Imazio M, Tidu M, et al. Infective endocarditis in drug
addicts: role of HIV infection and the diagnostic accuracy of Duke
criteria. J Cardiovasc Med 2007;8(3):169–75.
